Kanagawa, Japan

Kimio Kobayashi

USPTO Granted Patents = 2 

Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2006-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovation in Biotechnology: The Contributions of Kimio Kobayashi

Introduction:

Kimio Kobayashi, a pioneering inventor in the field of biotechnology, hails from Kanagawa, Japan. With a total of two patents to his name, Kobayashi has made significant advancements in the development of immunodeficient mice for various research purposes.

Latest Patents:

Kobayashi's groundbreaking latest patents focus on the creation of an immunodeficient mouse known as the NOG mouse. This innovative mouse model is specifically designed for the engraftment, differentiation, and proliferation of heterologous cells. By backcrossing different strains of mice and incorporating gene-knockout technology, Kobayashi has paved the way for producing human antibodies and establishing essential tools for stem cell assays, tumor modeling, and virus-infection studies.

Career Highlights:

Kimio Kobayashi is associated with the Central Institute for Experimental Animals, where his research and inventions have significantly impacted the field of biotechnology. His expertise in genetic engineering and mouse model development has earned him recognition among his peers and the scientific community.

Collaborations:

Throughout his career, Kobayashi has collaborated with esteemed colleagues such as Mamoru Ito and Tatsutoshi Nakahata. These partnerships have led to innovative research projects and the successful implementation of cutting-edge technologies in the field of biotechnology.

Conclusion:

In conclusion, Kimio Kobayashi stands as a key figure in the realm of biotechnological innovations, with his contributions revolutionizing the way researchers approach immunodeficient mouse models. His dedication to advancing scientific knowledge and his collaborative spirit continue to inspire breakthroughs in biomedicine and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…